Role of the Thoracic Surgery Research Foundation of Montreal in the funding ecosystem
The Thoracic Surgery Research Foundation of Montreal is a philanthropic foundation created in 2004 to advance thoracic surgery in Québec. It mobilizes individual and corporate donations and channels them into research chairs, structured research projects and highly specialized clinical programs in partnership with the CHUM and the Université de Montréal. The Foundation focuses on three main areas: thoracic oncology, oesophageal diseases and lung transplantation.
Through its fundraising activities and long-term partnerships, the Foundation helps recruit and retain academic thoracic surgeons and leading clinician‑scientists. It finances university chairs, advanced equipment, translational research projects and training activities that directly benefit patients suffering from lung and oesophageal diseases. Events such as the annual Black & White Gala and golf tournaments, as well as the Young Leaders Circle, provide recurring resources for these initiatives.
Main funding themes and instruments
- Research chairs and academic programs: endowed chairs in thoracic oncology, lung transplantation and oesophageal diseases provide stable funding for professors and their research teams.
- Clinical and translational research projects: the Foundation supports programs such as ex‑vivo lung perfusion for transplantation, minimally invasive techniques combining advanced imaging and navigation, organ reconditioning and regeneration, and molecular biology projects on tumour markers and genetic profiling.
- Specialized centres and platforms: it contributes to initiatives like the CHUM tracheobronchial and oesophageal evaluation centre (CETOC) and other high‑technology programs that improve diagnosis and treatment.
- Training and equipment: donations help acquire cutting‑edge equipment, support the training of medical students, residents and fellows, and strengthen multidisciplinary teams dedicated to thoracic surgery.
General approach to governance and allocation of funds
The governance section highlights a rigorous management model that keeps operating costs low so that funds raised can be directed as much as possible to researchers and their teams. Decisions are overseen by a board composed of health professionals, business leaders and community members, with a strong emphasis on transparency and the judicious use of donations.
The Foundation does not present open competitive grant calls on the site; instead, it operates as a discretionary philanthropic funder, structuring support around named chairs, institutional programs and strategic research priorities in thoracic surgery. Partners and major donors are closely associated with specific chairs and signature projects, and the Foundation regularly communicates scientific breakthroughs and research news to demonstrate the impact of the funding it provides.
Supported audiences and overall impact
The primary beneficiaries of the Foundation’s funding are patients affected by lung cancer, severe respiratory diseases requiring transplantation, and complex oesophageal disorders. By backing innovative research and highly specialized care, the Foundation aims to improve early detection, reduce surgical risk and recovery times, and increase survival and quality of life. It also supports the next generation of clinician‑researchers and helps maintain one of Canada’s largest thoracic surgery services in Montréal.